Riskpilot← Back to searchSign inGet full accessABBOTT DIAGNOSTICS TECHNOLOGIES AS
ASActiveOrg 981363019Kjelsåsveien 161, 0884 OsloManufacture of pharmaceutical preparations · NACE 2120Est. 1999298 employees
Revenue 2024
NOK 2B
+44% vs 2023
EBITDA margin
23.3%
+1653% vs 2023
Equity ratio
60.6%
Financial strength
Net profit 2024
NOK 382,4M
+514% vs 2023
| Revenue | NOK 2B | +44% |
| EBITDA | NOK 462,4M | +1653% |
| Net profit | NOK 382,4M | +514% |
| Total assets | NOK 1,4B | -15% |
| Equity | NOK 822,3M | -35% |
| Employees | 298 | — |
Legal name
ABBOTT DIAGNOSTICS TECHNOLOGIES AS
Org number
981363019
Legal form
Aksjeselskap
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
29. desember 1999
Share capital
NOK 2 000 000
Employees
298 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og daglig leder hver for seg.
Company purpose
Industri, handel og annen virksomhet som angår disse formål, samt å delta i andre selskap eller foretak med lignende formål, og alt hva som står i forbindelse med dette.
Address
Kjelsåsveien 161, 0884 Oslo
Phone
+4724056000
Email
webmasterindia@abbott.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 876 848 | 1 134 159 | 1 050 798 | 1 380 148 | 1 985 798 |
| Staff expenses | −159 252 | −140 037 | −147 214 | −169 949 | −0 |
| EBITDA | 192 720 | 340 091 | 121 306 | 26 385 | 462 445 |
| Depreciation & amort. | −28 597 | −31 811 | −34 083 | −32 889 | −27 068 |
| EBIT | 164 123 | 308 281 | 87 223 | −6 504 | 435 377 |
| Net financials | 5 345 | 4 987 | 58 436 | 85 266 | 54 527 |
| Profit before tax | 169 468 | 313 267 | 145 658 | 78 762 | 489 904 |
| Tax | 37 258 | −887 127 | 31 225 | 16 481 | −0 |
| Net profit | 132 210 | 3 342 489 | 114 433 | 62 281 | 382 416 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 349 342 | 4 993 691 | 3 099 622 | 1 596 123 | 1 357 262 |
| Equity | 956 596 | 449 085 | 2 363 518 | 1 264 890 | 822 306 |
| Long-term debt | 120 | 397 018 | 314 888 | 0 | 0 |
| Short-term debt | 392 627 | 4 147 587 | 421 215 | 331 233 | 534 957 |
| Total debt | 392 746 | 4 544 606 | 736 104 | 331 233 | 534 957 |
EBITDA margin
23.3%
This company
15.8%
Market median
+47% vs market
20202024
Equity ratio
60.6%
This company
38.2%
Market median
+59% vs market
20202024
Return on equity
46.5%
This company
18.4%
Market median
+153% vs market
20202024
Net profit margin
19.3%
This company
8.1%
Market median
+138% vs market
20202024
Asset turnover
1.46×
This company
1.12×
Market median
+30% vs market
20202024
Debt / equity
0.65×
This company
0.62×
Market median
+5% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LR Chief Executive Officer | Chief Executive Officer | 2025 |
| Former (2) | ||
TE Chief Executive Officer | Chief Executive Officer | 2021 – 2025 |
JG Chief Executive Officer | Chief Executive Officer | 2013 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Axis-Shield As
ABBOTT DIAGNOSTICS TECHNOLOGIES AS Board members of ABBOTT DIAGNOSTICS TECHNOLOGIES AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Todd Eric Thessen | Chief Executive Officer | 0 companies |
| Jorunn Grevle Lolland | Chief Executive Officer | 0 companies |
| Line Røed | Chief Executive Officer | 0 companies |
| Oddvar Arne Vanberg | Chairman | 0 companies |